Over-the-counter (OTC) drug and food safety and nutrition issues; OTC monograph User Fee Act (OMUFA) reauthorization; Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256).
2025 · 2nd Quarter (Apr 1 - June 30)
KINDERFARMS, LLC
Filed by HOLLAND & KNIGHT LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2025
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- HOLLAND & KNIGHT LLP
- Client
- KINDERFARMS, LLC
- Filing UUID
- 2cb666e3-47ff-4c2f-8589-1762104f2e66
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.